API reference
VALGANCICLOVIR HCl
- CAS number
- 175865-59-5
- Molecular formula
- C14H23ClN6O5
- Molecular weight
- 390.82 g/mol
About this molecule
Valganciclovir hydrochloride is an antiviral prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of cytomegalovirus retinitis (CMV retinitis) in adults with AIDS. Valganciclovir hydrochloride is also FDA-approved for the prevention of CMV disease in recipients of organ transplants who are at risk for CMV diseases. CMV diseases, including CMV retinitis, can be opportunistic infections(OIs) of HIV.
Source: Drug Database, Clinicalinfo.hiv.gov, via PubChem.
Identifiers
- IUPAC name
- [2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]-3-hydroxypropyl] (2S)-2-amino-3-methylbutanoate;hydrochloride
- InChIKey
- ZORWARFPXPVJLW-MTFPJWTKSA-N
- SMILES
- CC(C)[C@@H](C(=O)OCC(CO)OCN1C=NC2=C1N=C(NC2=O)N)N.Cl
- PubChem CID
- 135413534
Also known as
Valganciclovir hydrochloride · Valganciclovir HCl · Valcyte · Valcyt · VALGANCICLOVIR (AS HYDROCHLORIDE) · Valganciclovir hydrochloride powder, · Valganciclovir hydrochloride for Oral · C14H23ClN6O5
Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.
Tell us the grade, the quantity and the market.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.